NM4 logo

Vimab Group DB:NM4 Stock Report

Last Price

€0.70

Market Cap

€19.0m

7D

2.1%

1Y

-8.9%

Updated

19 Dec, 2024

Data

Company Financials

NM4 Stock Overview

Engages in the management consulting activities in the areas of energy services, and industrial and environmental technology in Sweden and internationally. More details

NM4 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Vimab Group AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vimab Group
Historical stock prices
Current Share PriceSEK 0.70
52 Week HighSEK 1.35
52 Week LowSEK 0.62
Beta-0.51
1 Month Change-14.91%
3 Month Change-6.70%
1 Year Change-8.90%
3 Year Changen/a
5 Year Changen/a
Change since IPO-29.27%

Recent News & Updates

Recent updates

Shareholder Returns

NM4DE Professional ServicesDE Market
7D2.1%-2.8%-2.6%
1Y-8.9%-50.3%7.1%

Return vs Industry: NM4 exceeded the German Professional Services industry which returned -50.5% over the past year.

Return vs Market: NM4 underperformed the German Market which returned 8% over the past year.

Price Volatility

Is NM4's price volatile compared to industry and market?
NM4 volatility
NM4 Average Weekly Movement35.9%
Professional Services Industry Average Movement4.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: NM4's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: NM4's weekly volatility has increased from 19% to 36% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011235Peter Fredellvimabgroup.com

Vimab Group AB (publ) engages in the management consulting activities in the areas of energy services, and industrial and environmental technology in Sweden and internationally. The company was incorporated in 2011 and is based in Motala, Sweden.

Vimab Group AB (publ) Fundamentals Summary

How do Vimab Group's earnings and revenue compare to its market cap?
NM4 fundamental statistics
Market cap€19.03m
Earnings (TTM)-€3.42m
Revenue (TTM)€30.89m

0.6x

P/S Ratio

-5.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NM4 income statement (TTM)
RevenueSEK 353.19m
Cost of RevenueSEK 256.96m
Gross ProfitSEK 96.23m
Other ExpensesSEK 135.36m
Earnings-SEK 39.13m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.64
Gross Margin27.25%
Net Profit Margin-11.08%
Debt/Equity Ratio179.6%

How did NM4 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 06:48
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vimab Group AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution